IRIS - Res&Arch Institutional Research Information System - Research & Archive

IRACI, NUNZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.305
EU - Europa 1.718
AS - Asia 1.490
SA - Sud America 283
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.260
SG - Singapore 530
UA - Ucraina 359
IE - Irlanda 291
VN - Vietnam 274
BR - Brasile 252
CN - Cina 241
HK - Hong Kong 236
SE - Svezia 233
IT - Italia 209
RU - Federazione Russa 189
GB - Regno Unito 111
DE - Germania 106
FI - Finlandia 93
KR - Corea 66
TR - Turchia 51
BE - Belgio 35
AR - Argentina 19
FR - Francia 19
CA - Canada 18
IN - India 17
MX - Messico 16
AT - Austria 14
BD - Bangladesh 12
PL - Polonia 12
CH - Svizzera 11
NL - Olanda 10
JP - Giappone 9
ZA - Sudafrica 9
UZ - Uzbekistan 8
ES - Italia 7
ID - Indonesia 6
IQ - Iraq 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
RO - Romania 5
CI - Costa d'Avorio 4
EU - Europa 4
MA - Marocco 4
PK - Pakistan 4
PY - Paraguay 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JO - Giordania 3
NP - Nepal 3
AM - Armenia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
GD - Grenada 2
IR - Iran 2
JM - Giamaica 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BZ - Belize 1
CM - Camerun 1
CO - Colombia 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.826
Salva come PNG Salva come JPEG
Città #
Chandler 349
Singapore 343
Dublin 289
Hong Kong 230
Dong Ket 211
Jacksonville 190
San Mateo 180
Perugia 103
Ashburn 102
Boardman 98
Santa Clara 88
Medford 77
Princeton 76
Seoul 66
Andover 65
Fremont 64
Beijing 63
Moscow 59
Wilmington 54
Dearborn 52
The Dalles 50
Ann Arbor 48
Izmir 40
Altamura 35
Brussels 34
São Paulo 33
Lawrence 30
Piscataway 29
Ho Chi Minh City 25
Los Angeles 24
Norwalk 23
Saint Petersburg 23
West Jordan 20
New York 18
Des Moines 15
Hanoi 15
Munich 14
Hefei 13
San Giustino 13
Helsinki 12
Brooklyn 11
Warsaw 11
Dallas 10
Redmond 10
Atlanta 9
Falls Church 9
Nanjing 9
Tokyo 9
Brasília 8
Auburn Hills 7
Houston 7
Manchester 7
Philadelphia 7
Shanghai 7
Simi Valley 7
Chicago 6
Denver 6
Johannesburg 6
Montreal 6
Recife 6
Redwood City 6
Rome 6
San Diego 6
San Francisco 6
Stockholm 6
Toronto 6
Zhengzhou 6
Ankara 5
Belo Horizonte 5
Chennai 5
Columbus 5
Den Haag 5
Guangzhou 5
Jinan 5
Lappeenranta 5
Phoenix 5
Poplar 5
San Paolo di Civitate 5
Spoleto 5
Teresina 5
Turku 5
Woodbridge 5
Abidjan 4
Asunción 4
Biên Hòa 4
Charlotte 4
London 4
Mcallen 4
Ribeirão Preto 4
Salvador 4
Vienna 4
Amman 3
Birmingham 3
Boston 3
Buenos Aires 3
Buffalo 3
Chengdu 3
Goiânia 3
Hangzhou 3
Hebei 3
Totale 3.611
Salva come PNG Salva come JPEG
Nome #
1,3-DIIDRO-BENZIMIDAZOLONI ANALOGHI: PROGETTAZIONE, SINTESI E SAR DI NUOVI INIBITORI NON-NUCLEOSIDICI DELL’RT 298
1,3-Diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 292
beta-CYCLODEXTRIN HINDERS PLGA PLASTICIZATION DURING MICROPARTICLE MANUFACTURING 164
Prion protein ligands as therapeutic agents for neurodegenerative disorders 129
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 110
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 107
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 104
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 101
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 96
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 96
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 94
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 94
Binding Mode Prediction of Strand Transfer HIV-1 Integrase Inhibitors Using Tn5 Transposase as a Plausible Surrogate Model for HIV-1 Integrase 92
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 90
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 88
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 88
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. 88
Design and synthesis of NR2B Subtype-Selective Antagonist 87
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 86
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non–Nucleoside reverse Transcriptase Inhibitors 85
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 84
Diselenides and benzisoselenazolones as antiproliferative agents and glutathione-S-transferase inhibitors 84
Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 83
Nuovi antagonisti non-competitivi del recettore NMDA/NR2B:design and sintesi 83
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 83
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 83
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 82
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 80
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 80
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 80
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 80
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 78
DECODING THE FUNCTION OF THE N-TERMINAL TAIL OF THE CELLULAR PRION PROTEIN TO INSPIRE NOVEL THERAPEUTIC AVENUES FOR NEURODEGENERATIVE DISEASES 78
Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin. 76
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 73
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 71
Exploration of the binding mode of HIV-1 integrase strand transfer inhibitors through different computational approaches. 70
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 69
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 69
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 68
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 67
Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’ HIV-1 Mediante Tecniche di Virtual screening. 67
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 67
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 67
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 65
Nuovo modello farmacoforico per inibitori dell’Integrasi dell’HIV-1: ottimizzazione della potenza di composti a struttura 1H-benzilindolica 64
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series. 63
Nuovi chemotipi di inibitori dell'HCV NS5B polimerasi 62
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 61
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 61
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 61
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 61
New chemotypes to fight HCV infection: discovery of selective inhibitors of HCV replication with pyrazolobenzothiazine scaffold 60
Tn5 Transposase as a useful platform to simulate HIV-1 Integrase inhibitor binding mode 60
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 59
Rational design, synthesis and SAR of 1,3-dihydro- benzimidazolone analogues as new anti-HIV agents 58
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 58
Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication 58
Studi Computazionali per l’Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’HIV- 56
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors. 56
Pharmacological agents targeting the cellular prion protein 55
Docking studies on a new HIV integrase–Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 55
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 54
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 54
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 52
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 51
NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors 51
Progettazione, sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 50
Pharmacophore Modeling, Docking Experiments And Discovery Of New HIV-1 NNRTIs. 50
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 50
NCp7: Targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders 50
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. 48
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 47
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 47
Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. 46
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. 43
L-arginine improves solubility and anti sars-cov-2 mpro activity of rutin but not the antiviral activity in cells 34
Totale 6.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021540 0 0 0 0 0 77 59 5 94 26 56 223
2021/2022708 16 135 12 37 47 7 5 231 27 15 88 88
2022/2023989 82 141 15 91 82 109 0 56 356 2 33 22
2023/2024481 36 62 23 11 5 8 73 35 63 29 68 68
2024/2025984 2 104 27 107 99 12 76 25 197 98 159 78
2025/20261.016 160 177 106 303 228 42 0 0 0 0 0 0
Totale 6.011